Global Biosimilars Market Survey and Trend Research 2018

December 2017 | 89 pages | ID: G4F655D47ACEN
99Strategy

Abstracts

Summary

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Sandoz International, Hospira, Teva Pharmaceutical, Dr. Reddy’s Laboratories, Mylan, Mylan, Amgen, Celltrion, Roche Diagnostics?, Merck KGaA etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Biosimilars Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 BIOSIMILARS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Sandoz International (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Hospira (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Teva Pharmaceutical (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Dr. Reddy’s Laboratories (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 Mylan (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 Mylan (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Amgen (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Celltrion (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Roche Diagnostics? (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Merck KGaA (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Biosimilars Market 2012-2017, by Type, in USD Million
Table Global Biosimilars Market 2012-2017, by Type, in Volume
Table Global Biosimilars Market Forecast 2018-2023, by Type, in USD Million
Table Global Biosimilars Market Forecast 2018-2023, by Type, in Volume
Table Sandoz International Overview List
Table Biosimilars Business Operation of Sandoz International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hospira Overview List
Table Biosimilars Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Overview List
Table Biosimilars Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dr. Reddy’s Laboratories Overview List
Table Biosimilars Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Biosimilars Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Biosimilars Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Celltrion Overview List
Table Biosimilars Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Diagnostics? Overview List
Table Biosimilars Business Operation of Roche Diagnostics? (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Overview List
Table Biosimilars Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Biosimilars Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Biosimilars Sales Revenue Share, by Companies, in USD Million
Table Global Biosimilars Sales Volume 2012-2017, by Companies, in Volume
Table Global Biosimilars Sales Revenue Share, by Companies in 2017, in Volume
Table Biosimilars Demand 2012-2017, by Application, in USD Million
Table Biosimilars Demand 2012-2017, by Application, in Volume
Table Biosimilars Demand Forecast 2018-2023, by Application, in USD Million
Table Biosimilars Demand Forecast 2018-2023, by Application, in Volume
Table Global Biosimilars Market 2012-2017, by Region, in USD Million
Table Global Biosimilars Market 2012-2017, by Region, in Volume
Table Biosimilars Market Forecast 2018-2023, by Region, in USD Million
Table Biosimilars Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Biosimilars Industry Chain Structure
Figure Global Biosimilars Market Growth 2012-2017, by Type, in USD Million
Figure Global Biosimilars Market Growth 2012-2017, by Type, in Volume
Figure Global Biosimilars Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Biosimilars Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region